298 related articles for article (PubMed ID: 27278751)
21. Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model.
Ajorlou E; Khosroushahi AY; Yeganeh H
Pharm Res; 2016 Jun; 33(6):1426-39. PubMed ID: 26908046
[TBL] [Abstract][Full Text] [Related]
22. iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.
Simón-Gracia L; Hunt H; Scodeller P; Gaitzsch J; Kotamraju VR; Sugahara KN; Tammik O; Ruoslahti E; Battaglia G; Teesalu T
Biomaterials; 2016 Oct; 104():247-57. PubMed ID: 27472162
[TBL] [Abstract][Full Text] [Related]
23. Development of stabilized Paclitaxel nanocrystals: In-vitro and in-vivo efficacy studies.
Sharma S; Verma A; Teja BV; Shukla P; Mishra PR
Eur J Pharm Sci; 2015 Mar; 69():51-60. PubMed ID: 25559064
[TBL] [Abstract][Full Text] [Related]
24. Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential blood-brain barrier penetration and glioma targeting therapy.
Zhang P; Hu L; Yin Q; Feng L; Li Y
Mol Pharm; 2012 Jun; 9(6):1590-8. PubMed ID: 22497485
[TBL] [Abstract][Full Text] [Related]
25. Superior intratumoral penetration of paclitaxel nanodots strengthens tumor restriction and metastasis prevention.
Ni D; Ding H; Liu S; Yue H; Bao Y; Wang Z; Su Z; Wei W; Ma G
Small; 2015 Jun; 11(21):2518-26. PubMed ID: 25678130
[TBL] [Abstract][Full Text] [Related]
26. TAT Peptide-Conjugated Magnetic PLA-PEG Nanocapsules for the Targeted Delivery of Paclitaxel: In Vitro and Cell Studies.
Koutsiouki K; Angelopoulou A; Ioannou E; Voulgari E; Sergides A; Magoulas GE; Bakandritsos A; Avgoustakis K
AAPS PharmSciTech; 2017 Apr; 18(3):769-781. PubMed ID: 27301873
[TBL] [Abstract][Full Text] [Related]
27. Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles.
Jiang X; Xin H; Gu J; Du F; Feng C; Xie Y; Fang X
J Pharm Sci; 2014 May; 103(5):1487-96. PubMed ID: 24619482
[TBL] [Abstract][Full Text] [Related]
28. Ultrasound contrast-enhanced imaging and in vitro antitumor effect of paclitaxel-poly(lactic-co-glycolic acid)-monomethoxypoly (ethylene glycol) nanocapsules with ultrasound-targeted microbubble destruction.
Ma J; Xing LX; Shen M; Li F; Zhu MJ; Jin LF; Li Z; Gao F; Su Y; Duan YR; Du LF
Mol Med Rep; 2015 Apr; 11(4):2413-20. PubMed ID: 25500683
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agents.
Boissenot T; Fattal E; Bordat A; Houvenagel S; Valette J; Chacun H; Gueutin C; Tsapis N
Eur J Pharm Biopharm; 2016 Nov; 108():136-144. PubMed ID: 27594209
[TBL] [Abstract][Full Text] [Related]
30. Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis.
Zhang H; Hu H; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Nanoscale; 2015 Jun; 7(24):10790-800. PubMed ID: 26038337
[TBL] [Abstract][Full Text] [Related]
31. Novel thermo-sensitive hydrogel system with paclitaxel nanocrystals: High drug-loading, sustained drug release and extended local retention guaranteeing better efficacy and lower toxicity.
Lin Z; Gao W; Hu H; Ma K; He B; Dai W; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2014 Jan; 174():161-70. PubMed ID: 24512789
[TBL] [Abstract][Full Text] [Related]
32. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation.
Hu C; Huang Y; Chen Y
Mol Pharm; 2019 Feb; 16(2):561-572. PubMed ID: 30592418
[TBL] [Abstract][Full Text] [Related]
33. Targeted co-delivery of protein and drug to a tumor in vivo by sophisticated RGD-modified lipid-calcium carbonate nanoparticles.
Peng JQ; Fumoto S; Suga T; Miyamoto H; Kuroda N; Kawakami S; Nishida K
J Control Release; 2019 May; 302():42-53. PubMed ID: 30926479
[TBL] [Abstract][Full Text] [Related]
34. iRGD-mediated core-shell nanoparticles loading carmustine and O
Liu C; Yao S; Li X; Wang F; Jiang Y
J Drug Target; 2017 Mar; 25(3):235-246. PubMed ID: 27646474
[TBL] [Abstract][Full Text] [Related]
35. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors.
Ye J; Liu Y; Xia X; Meng L; Dong W; Wang R; Fu Z; Liu H; Han R
Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803
[TBL] [Abstract][Full Text] [Related]
36. Development of multifunctional lipid nanocapsules for the co-delivery of paclitaxel and CpG-ODN in the treatment of glioblastoma.
Lollo G; Vincent M; Ullio-Gamboa G; Lemaire L; Franconi F; Couez D; Benoit JP
Int J Pharm; 2015 Nov; 495(2):972-80. PubMed ID: 26428632
[TBL] [Abstract][Full Text] [Related]
37. Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability.
Hu C; Chen X; Huang Y; Chen Y
Sci Rep; 2018 Feb; 8(1):2274. PubMed ID: 29396568
[TBL] [Abstract][Full Text] [Related]
38. Photo-responsive and NGR-mediated multifunctional nanostructured lipid carrier for tumor-specific therapy.
Yang Y; Xie X; Yang Y; Zhang H; Mei X
J Pharm Sci; 2015 Apr; 104(4):1328-39. PubMed ID: 25630979
[TBL] [Abstract][Full Text] [Related]
39. iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery.
Ma L; Chen Q; Ma P; Han MK; Xu Z; Kang Y; Xiao B; Merlin D
Nanomedicine (Lond); 2017 Aug; 12(16):1991-2006. PubMed ID: 28745123
[TBL] [Abstract][Full Text] [Related]
40. Lipid and Biosurfactant Based Core-Shell-Type Nanocapsules Having High Drug Loading of Paclitaxel for Improved Breast Cancer Therapy.
Katiyar SS; Ghadi R; Kushwah V; Dora CP; Jain S
ACS Biomater Sci Eng; 2020 Dec; 6(12):6760-6769. PubMed ID: 33320604
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
